Treace Medical Concepts (TMCI) Competitors $5.82 +0.39 (+7.18%) (As of 11:11 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TMCI vs. ANGO, SGHT, ORGO, FNA, SIBN, AORT, BLFS, BVS, MDXG, and PLSEShould you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include AngioDynamics (ANGO), Sight Sciences (SGHT), Organogenesis (ORGO), Paragon 28 (FNA), SI-BONE (SIBN), Artivion (AORT), BioLife Solutions (BLFS), Bioventus (BVS), MiMedx Group (MDXG), and Pulse Biosciences (PLSE). These companies are all part of the "medical" sector. Treace Medical Concepts vs. AngioDynamics Sight Sciences Organogenesis Paragon 28 SI-BONE Artivion BioLife Solutions Bioventus MiMedx Group Pulse Biosciences Treace Medical Concepts (NASDAQ:TMCI) and AngioDynamics (NASDAQ:ANGO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership and dividends. Do analysts recommend TMCI or ANGO? Treace Medical Concepts presently has a consensus price target of $7.00, indicating a potential upside of 28.91%. AngioDynamics has a consensus price target of $12.00, indicating a potential upside of 78.04%. Given AngioDynamics' stronger consensus rating and higher probable upside, analysts clearly believe AngioDynamics is more favorable than Treace Medical Concepts.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treace Medical Concepts 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00AngioDynamics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation & earnings, TMCI or ANGO? Treace Medical Concepts has higher earnings, but lower revenue than AngioDynamics. Treace Medical Concepts is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreace Medical Concepts$187.12M1.80-$49.53M-$1.02-5.32AngioDynamics$292.73M0.94-$184.35M-$6.09-1.11 Is TMCI or ANGO more profitable? Treace Medical Concepts has a net margin of -32.08% compared to AngioDynamics' net margin of -83.95%. AngioDynamics' return on equity of -5.86% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets Treace Medical Concepts-32.08% -49.53% -26.50% AngioDynamics -83.95%-5.86%-4.17% Do insiders and institutionals hold more shares of TMCI or ANGO? 84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 89.4% of AngioDynamics shares are owned by institutional investors. 24.4% of Treace Medical Concepts shares are owned by company insiders. Comparatively, 5.4% of AngioDynamics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media prefer TMCI or ANGO? In the previous week, Treace Medical Concepts had 11 more articles in the media than AngioDynamics. MarketBeat recorded 12 mentions for Treace Medical Concepts and 1 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 0.07 beat Treace Medical Concepts' score of -0.12 indicating that AngioDynamics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 1 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral AngioDynamics 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Does the MarketBeat Community believe in TMCI or ANGO? AngioDynamics received 343 more outperform votes than Treace Medical Concepts when rated by MarketBeat users. Likewise, 61.06% of users gave AngioDynamics an outperform vote while only 48.00% of users gave Treace Medical Concepts an outperform vote. CompanyUnderperformOutperformTreace Medical ConceptsOutperform Votes2448.00% Underperform Votes2652.00% AngioDynamicsOutperform Votes36761.06% Underperform Votes23438.94% Which has more volatility & risk, TMCI or ANGO? Treace Medical Concepts has a beta of 0.24, meaning that its stock price is 76% less volatile than the S&P 500. Comparatively, AngioDynamics has a beta of 0.67, meaning that its stock price is 33% less volatile than the S&P 500. SummaryAngioDynamics beats Treace Medical Concepts on 12 of the 18 factors compared between the two stocks. Ad DarwinUnlock the Secret to Earning Consistent Income from Stocks Under $30!Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!👉 Yes, I Want the Free Report! 👈 Get Treace Medical Concepts News Delivered to You Automatically Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMCI vs. The Competition Export to ExcelMetricTreace Medical ConceptsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$297.27M$4.43B$5.10B$8.43BDividend YieldN/A42.39%7.52%4.16%P/E Ratio-5.3243.36133.4116.50Price / Sales1.8061.051,617.6575.90Price / CashN/A49.2237.2033.56Price / Book2.424.424.594.98Net Income-$49.53M$11.84M$116.16M$224.69M7 Day Performance12.66%-0.34%-0.97%-0.51%1 Month Performance1.69%2.49%5.32%3.32%1 Year Performance-50.82%35.52%33.76%25.51% Treace Medical Concepts Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMCITreace Medical Concepts1.8897 of 5 stars$5.82+7.2%$7.00+20.3%-50.8%$361.95M$187.12M-5.71250News CoverageANGOAngioDynamics4.3775 of 5 stars$6.68-0.1%$12.00+79.6%-1.0%$271.41M$303.91M-1.10748SGHTSight Sciences2.29 of 5 stars$5.21+4.2%$7.25+39.2%+156.0%$262.10M$79.40M-4.87210Upcoming EarningsAnalyst DowngradeORGOOrganogenesis4.0474 of 5 stars$2.78+0.4%$4.88+75.4%+26.2%$368.55M$433.14M-21.38950Upcoming EarningsNews CoverageFNAParagon 282.3994 of 5 stars$5.62+6.0%$15.25+171.4%-40.4%$469.51M$235.44M-8.14343,000Upcoming EarningsSIBNSI-BONE4.2211 of 5 stars$13.49-2.2%$22.67+68.0%-24.2%$562.40M$138.89M-13.36350Upcoming EarningsPositive NewsAORTArtivion2.0113 of 5 stars$26.75+1.6%$30.60+14.4%+93.0%$1.12B$354M-127.381,500Upcoming EarningsBLFSBioLife Solutions0.7186 of 5 stars$24.07+2.9%$26.67+10.8%+123.8%$1.11B$143.27M-14.24409Upcoming EarningsBVSBioventus1.6655 of 5 stars$13.58+0.1%$12.00-11.6%+257.0%$1.10B$512.34M-20.581,200News CoverageGap DownMDXGMiMedx Group3.7764 of 5 stars$6.93+1.2%$12.00+73.2%+4.5%$1.02B$340.46M12.60895Analyst RevisionPLSEPulse Biosciences1.201 of 5 stars$14.56-16.5%N/A+208.7%$895.73M$700,000.000.00140Earnings Report Related Companies and Tools Related Companies AngioDynamics Alternatives Sight Sciences Alternatives Organogenesis Alternatives Paragon 28 Alternatives SI-BONE Alternatives Artivion Alternatives BioLife Solutions Alternatives Bioventus Alternatives MiMedx Group Alternatives Pulse Biosciences Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TMCI) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Treace Medical Concepts, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Treace Medical Concepts With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
